Related Experiment Video
Updated: Jun 29, 2025
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Illuminating Progress: A Comprehensive Review of the Evolution of Phototherapy for Neonatal Hyperbilirubinemia
Ankita Patel1, Jayant D Vagha1, Revat J Meshram1
1Pediatrics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Insights
Phototherapy effectively treats neonatal hyperbilirubinemia, a common condition in newborns. This review details its history, physiology, and modern advancements for improved infant care.
Area of Science:
- Neonatal Medicine
- Pediatric Photobiology
- Clinical Biochemistry
Background:
- Neonatal hyperbilirubinemia is common due to immature newborn liver function.
- Elevated bilirubin levels can lead to neurotoxicity if untreated.
- Phototherapy is a primary treatment for reducing bilirubin in infants.
Purpose of the Study:
- To review the historical, physiological, and contemporary aspects of phototherapy for neonatal hyperbilirubinemia.
- To highlight advancements in phototherapy techniques and their clinical implications.
- To provide insights for optimizing neonatal care strategies.
Main Methods:
- Comprehensive literature review of phototherapy in neonatal hyperbilirubinemia.
- Analysis of historical data, physiological mechanisms, and current research.
- Examination of clinical applications and technological advancements.
Main Results:
- Phototherapy demonstrates consistent efficacy in lowering unconjugated bilirubin levels.
- Historical evolution shows significant advancements in phototherapy modalities.
- Modern phototherapy, enhanced by monitoring systems, improves precision and safety.
Conclusions:
- Phototherapy remains a cornerstone in managing neonatal hyperbilirubinemia.
- Tailoring treatment based on infant characteristics and jaundice severity is crucial.
- Future research should focus on long-term outcomes, adjunctive therapies, and global accessibility.
Abstract:
This comprehensive review thoroughly examines the historical evolution, physiological foundations, and contemporary advancements in the application of phototherapy for neonatal hyperbilirubinemia. Neonatal hyperbilirubinemia, a common condition resulting from the immature hepatic processes in newborns, poses potential risks, including neurotoxicity, if left untreated. The review traces the historical progression from early recognition of neonatal jaundice to the development of various phototherapy modalities, showcasing the dynamic landscape of neonatal care. Emphasizing the physiological intricacies of bilirubin metabolism in neonates, the study underscores the vulnerability of newborns to hyperbilirubinemia due to delayed hepatic maturation. Phototherapy is a cornerstone in managing hyperbilirubinemia, demonstrating consistent efficacy in reducing unconjugated bilirubin levels. The implications for clinical practice are significant, offering healthcare professionals insights into tailoring treatment strategies based on individual neonatal characteristics and the severity of jaundice. Integrating advanced monitoring and control systems enhances the precision and safety of phototherapy. Recommendations for future research emphasize the need to investigate long-term outcomes, explore adjunctive therapies, and address resource limitations to ensure global access to effective neonatal care. Overall, this review contributes to the ongoing refinement of neonatal care practices, offering a comprehensive understanding of neonatal hyperbilirubinemia and its evolving treatment landscape.
